A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

October 31, 2011

Conditions
ChondrosarcomasAlveolar Soft Part SarcomasExtra Skeletal Myxoid Chondrosarcomas
Interventions
DRUG

Perifosine

Perifosine is available in 50 mg tablets. Patients will take two perifosine 50 mg tablets orally once a day at bedtime with food.

OTHER

Loperamide

All patients should be instructed to take loperamide at the earliest signs of diarrhea and/or abdominal cramping after beginning perifosine.

OTHER

Allopurinol

Patients with a known history of hyperuricemia and/or gout should receive prophylactic treatment with allopurinol 300 mg po daily.

OTHER

Antiemetics

Antiemetic prophylaxis will be administered at the treating investigator's discretion.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sarcoma Alliance for Research through Collaboration

OTHER

lead

AEterna Zentaris

INDUSTRY